CNF2 Antibodies

Santa Cruz Biotechnology offers a broad range of CNF2 Antibodies for various research applications. CNF2 Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CNF2, or Cytotoxic Necrotizing Factor 2, is a bacterial protein that plays a crucial role in modulating host cell signaling pathways, particularly those involved in cytoskeletal dynamics and immune response. The ability of CNF2 to manipulate Rho GTPases makes it an important factor in understanding bacterial pathogenesis and host-pathogen interactions. Research on CNF2 can provide insights into potential therapeutic targets for diseases caused by pathogenic bacteria. CNF2 monoclonal antibodies enable detailed investigation of bacterial infection mechanisms and their effects on host cells. Understanding CNF2's molecular interactions helps advance knowledge of bacterial virulence factors and their impact on human health. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of bacterial pathogenesis and developing new therapeutic strategies.